Anti-programmed Death-1 Inhibitors and Nimotuzumab in Combination with Induction Chemotherapy for Locoregionally Advanced Nasopharyngeal Carcinoma: a Propensity Score-Matched Analysis
THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY（2025）
Key words
immunotherapy,nasopharyngeal carcinoma,neoadjuvant therapy,nimotuzumab,PD-1 inhibitors
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined